NIT
ALXN

NumerixS Investment Technologies’s Alexion Pharmaceuticals ALXN Stock Holding History

NumerixS Investment Technologies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,100
Closed -$236K – 989
2020
Q2 		$236K Buy
2,100
+633
+43% +$67.2K 0.07% 343
2020
Q1 		$132K Sell
1,467
-6,379
-81% -$626K 0.07% 354
2019
Q4 		$849K Sell
7,846
-743
-9% -$79.5K 0.17% 135
2019
Q3 		$841K Buy
+8,589
New +$968K 0.22% 97
2018
Q3 		– Sell
-4,200
Closed -$511K – 1431
2018
Q2 		$511K Buy
+4,200
New +$491K 0.12% 247
2017
Q4 		– Sell
-13,200
Closed -$1.85M – 1432
2017
Q3 		$1.85M Buy
13,200
+4,845
+58% +$658K 0.41% 38
2017
Q2 		$1.02M Buy
8,355
+2,659
+47% +$309K 0.15% 166
2017
Q1 		$691K Buy
+5,696
New +$734K 0.08% 310
2016
Q4 		– Sell
-14,740
Closed -$1.81M – 1403
2016
Q3 		$1.81M Buy
14,740
+6,347
+76% +$817K 0.23% 93
2016
Q2 		$980K Buy
+8,393
New +$1.19M 0.14% 215
2015
Q2 		– Sell
-4,000
Closed -$693K – 785
2015
Q1 		$693K Buy
+4,000
New +$724K 0.13% 221

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NumerixS Investment Technologies's ALXN Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Alexion Pharmaceuticals (ALXN) in Q3 2020, closing a stake of 2,100 shares — an estimated $236K sold.

NumerixS Investment Technologies first reported a position in ALXN in Q1 2015 and held it in 11 quarters. The position peaked at $1.85M in Q3 2017. 707 funds tracked by Wall St. Rank hold ALXN as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Alexion Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,100 Alexion Pharmaceuticals shares in Q3 2020, an estimated $236K.
  • NumerixS Investment Technologies first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • NumerixS Investment Technologies's Alexion Pharmaceuticals position peaked at $1.85M in Q3 2017.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.